Related Experiment Video
Updated: Jun 9, 2025

09:26
Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication
Published on: February 6, 2019
18.7K
Post-Movement Beta Synchrony Inhibits Cortical Excitability.
Edward Rhodes1,2, William Gaetz3, Jonathan Marsden1,4
1Brain Research & Imaging Centre, University of Plymouth, Plymouth PL4 8AA, UK.
Brain Sciences
|October 25, 2024
Summary
Post-movement beta rebound (PMBR) signifies reduced motor cortex excitability, confirming its role in cortical inhibition. This research clarifies beta oscillations
Area of Science:
- Neuroscience
- Motor Control
- Brain Oscillations
Background:
- Voluntary movement involves beta oscillations in the primary motor cortex (M1).
- Post-movement beta rebound (PMBR) follows beta-event related desynchronization (B-ERD) and is linked to cortical inhibition.
- The precise temporal relationship between PMBR and motor cortical excitability remains unclear.
Purpose of the Study:
- To investigate the relationship between movement-related beta synchrony and M1 excitability.
- To determine if PMBR serves as a marker for post-movement cortical inhibition.
- To assess motor-evoked potentials (MEPs) during distinct phases of beta synchrony.
Main Methods:
- Twenty-five healthy participants performed a reaction time task.
- Electromyography (EMG) recorded muscle activity, and transcranial magnetic stimulation (TMS) assessed M1 excitability.
- MEPs were measured during B-ERD, early PMBR, peak PMBR, and late PMBR phases.
Main Results:
- Cortical excitability, measured by MEP amplitude, increased during B-ERD compared to rest.
- MEP amplitude significantly decreased during peak PMBR, indicating cortical inhibition.
- All PMBR phases showed reduced cortical excitability, with a trend towards amplitude-dependent inhibition.
Conclusions:
- PMBR is confirmed as a marker of reduced motor cortical excitability and inhibition.
- Findings enhance understanding of beta oscillations in motor control.
- Altered PMBR may be relevant for neurological and psychiatric disorders.

